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duction. Morphological assessment using electron microscope revealed that mi-
tochondria in the hearts of STZ-induced diabetic rats were swollen and the struc-
ture of cristae was collapsed; however, these changes were attenuated by the
treatment with KN-93 and apocynin. This observation indicates that activation of
CaMKII followed by NADPH oxidase-derived ROS increase contributes to mito-
chondrial dysfunction which may lead to cell death.
Conclusion: Increase in NADPH oxidase by activating CaMKII is a mechanism
of ROS increase in the heart of diabetes mellitus. Up-regulation of ROS produc-
tion facilitates mitochondrial malfunction and may result in cardiac dysfunction in
diabetic patients.
239 The soluble guanylate cyclase activator cinaciguat
improves cardiac dysfunction in diabetes mellitus
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G. Szabo3 , B. Merkely1 . 1Semmelweis University, Heart Center,
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Purpose: Patients with diabetes mellitus exhibit cardiovascular dysfunction along
with increased oxidative stress and decreased nitric oxide – cyclic guanosine
monophosphate (cGMP) signalling. It has been reported, that elevated intracellu-
lar cGMP-levels contribute to an effective cytoprotection against oxidative stress.
In this study we investigated the effects of cinaciguat, a newly developed soluble
guanylate cyclase activator on myocardial dysfunction in type-1 diabetic rats.
Methods: In male Sprague-Dawley rats diabetes was induced by a single
ip. injection of streptozotocin (60mg/kg). In the treatment groups, cinaciguat
(10mg/kg/d) was applied orally for 8 weeks. Rats of the control groups received
vehicle for the same time. After the treatment left ventricular (LV) pressure-volume
relations were measured by using a microtip Millar pressure-volume conduc-
tance catheter, and indexes of contractility (e.g. preload recruitable stroke work
(PRSW)) were calculated. Blood plasma and myocardial tissue samples were
collected for determination of cGMP-levels and immunohistochemical analysis,
respectively. Myocardial gene expression analysis has been performed by quan-
titative real-time polymerase chain reaction (qRT-PCR).
Results: When compared to the non-diabetic controls, diabetic rats showed im-
paired left ventricular contractility (PRSW: 49.5±3.3 vs. 83.0±5.5mmHg; p<0.05)
and a marked diastolic dysfunction (time constant of LV pressure decay, Tau:
17.3±0.8 vs. 10.3±0.3ms), which was significantly improved by cinaciguat
(PRSW: 66.8±3.6mmHg, Tau: 14.9±0.6ms in the diabetes+cinaciguat group).
The treatment had no hemodynamic effects in non-diabetic control animals. Di-
abetes was associated with increased myocardial immunoreactivity for trans-
forming growth factor beta (TGF-b) along with enhanced gene expression for
atrial natriuretic peptide (ANP), heat shock protein 70 (Hsp70) and matrix
metalloproteinase-9 (MMP-9), which were all reversed after cinaciguat treatment.
Efficacy of the therapy was reflected by markedly elevated levels of cGMP in the
diabetes+cinaciguat group compared to control (44.2±11.4 vs. 16.1±2.0pmol/ml
plasma).
Conclusions: Our results demonstrate that cinaciguat prevents diabetes-
associated deleterious myocardial changes and improves diabetic cardiac dys-
function in our rat model. Pharmacological soluble guanylate cyclase activation
might represent a novel therapy approach for diabetic cardiomyopathy.
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Background: Ischemic preconditioning involves activation of multiple signal-
ing pathways with mitochondrial ion channels as an end-effector. Recently, we
demonstrated that connexin 43 hemichannels found in the inner mitochondrial
membrane (mito-Cx43 hemi) are essential for cytoprotective signal transduction.
Heart failure is a vulnerable disease state in which any additional myocardial dam-
age may lead to acute circulatory failure. However, susceptibility to ischemic injury
and the protective potential of IP in heart failure are unresolved.
Methods:We aimed to directly prove the presence of human mito-Cx43 hemi and
to evaluate channel characteristics in failing versus non-failing myocardium. Fur-
thermore we combined heart failure with ischemia-reperfusion injury in a mouse
model. We used direct single-channel recordings of cardiac mitochondria to pos-
sibly identify a functional link between mito-Cx43 hemi and susceptibility to is-
chemic injury in murine and human heart failure.
Results: We identified single-channel currents, which were clearly distinct from
mitoKATP channels, inhibited by the Cx43 mimetic peptide 43GAP27 which sup-
pressed open probability and single-channel conductance. Single-channel prop-
erties thus supported the notion that we were recording mitochondrial Cx43 chan-
nels. Basal mito-Cx43 hemi activity was increased in both human and murine
heart failure. A pharmacological preconditioning with diazoxide stimulated single-
channels of failing and non-failing hearts to a similar maximal activity. Despite a
reduced content and dephosphorylation of total Cx43 in failing hearts, mitochon-
drial Cx43 was increased and hyperphosphorylated.
Conclusion: For the first time we directly recorded human mitoCx43 hemichan-
nels which were inhibited by 43GAP27. Our results indicate endogenous pro-
tective adaptation mediated via enhanced basal mito-Cx43 hemichannel activity
through hyperphosphorylation of the mitochondrial Cx43 fraction in heart failure.
241 Glucagon-like peptide-1 receptor activation ameliorates
cardiac steatosis and reverses pathological remodeling
by quality control of mitochondria via cAMP/PKA axis
A. Monji, Y. Kureishi Bando, M. Aoyama, T. Shigeta, T. Mitsui,
T. Murohara. Nagoya University Graduate School of Medicine,
Department of Cardiology, Nagoya, Japan
Purpose: Glucagon-like peptide-1 receptor (GLP-1R) agonist exendin-4 facili-
tates cardiac contractility in systolic dysfunction model in rodents and patients
with heart failure. However, the impact of GLP-1R on cardiac steatosis remains
unclear.
Methods and Results: Male KK/Ay mice (16-week-old) were allocated into
exendin-4 (24 nmole/kg/day, 40 days; KK-ex4) and vehicle group (KK-v). Male
C57BL6 mice were fed with high fat diet for 3 months (DIO) and subjected to
exendin-4 treatment at the age of 16 week old (DIO-ex4 and DIO-v). KK-ex4 ex-
hibited decline in heart weight (-16.5% vs KK-v) without body weight loss. Oil-red-
O staining revealed that KK-ex4 and DIO-ex4 reduced cardiac steatosis. Echo-
cardiography revealed that systolic function of DIO-v was suppressed (-13.8% vs
control), which was restored in DIO-ex4 with reduced LVPWd (-11.1% vs DIO-v)
and IVSd (-30.0% vs DIO-v). Myocardial fibrosis and tissue oxidative stress de-
tected by DHE staining were reduced in KK-ex4 and DIO-ex4 (0.45±0.10 fold and
0.58±0.10 fold vs vehicle). Transmission electron microscopy revealed restoration
of irregular alignment and increase in number of mitochondria with normal cristae
in KK-ex4 and DIO-ex4. Mitochondria-specific dyes (MitoTracker Red) revealed
decline in oxidative activity of cardiac mitochondria both in KK-ex4 and DIO-ex4.
The levels of myocardial PINK/Parkin, the surrogate indicators for damaged mito-
chondria, were reduced both in KK-ex4 and DIO-ex4.
Figure 1. Typical mitochondria images by TEM
Conclusion: GLP-1R activation protects cardiac remodeling induced by steatosis
through the restoring mitochondrial oxidative damage mediated by the activation
of cAMP/PKA-dependent mechanisms.
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Purpose: Nesfatin-1 is a novel adipokine involved in the control of food intake
and energy metabolism which shows anti-inflammatory properties. The role of
this adipokine in cardiovascular physiology is unknown. In previous studies we
determined that nesfatin-1 is expressed in human, rat and mouse heart. Our aim
now is to study the effect of this adipokine in cardiomyocytes and the possible
regulation of nesfatin-1 cardiac synthesis by diet and inflammatory mediators.
Methods: Real-time PCR was used to determine nesfatin-1 mRNA levels in cul-
tured neonatal cardiomyocytes of Sprague Dawley rats treated with TNF-α, dex-
amethasone and insulin. In heart tissue of rats fed with high fat diet for 16 weeks,
we used real-time PCR to determine nesfatin-1 cardiac mRNA levels and an
ELISA to determine nesfatin-1 plasma levels. Cardiomyocytes were treated with
nesfatin-1 and confocal microscopy was used to study the glucose transporter
Glut-4 movilization. Finally, western blot was used to identify possible transduc-
ing signalling molecules (Erk 1
2
, AMPK and AKT) after nesfatin-1 treatment in
cardiomyocytes.
Results: Cardiomyocytes treatment with 0.1-20 ng/ml TNF-α for 6-48 h induces
an increase of nesfatin-1 mRNA levels with a maximum stimulatory effect at 20
ng/ml for 24 h (p=0.0159; Fold-Change (FC)=1.16, n=5). Treatment with 0.1-100
nM dexamethasone for 6-48 h also increases of nesfatin-1 mRNA levels with
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On the other hand, 0.1-100 nM insulin treatment for 6-48 h decreases nesfatin-1
mRNA levels with a maximum stimulatory effect at 100 nM for 24 h (p=0.0159;
FC= -0.6962, n=5). Treatment of cardiomyocytes with 10-1000 nM nesfatin-1
for 5-30 minutes induces Glut-4 movilization from the cytoplasm to the plasma
membrane (p=0.0007; FC=1.125, n=216 cells) and an Erk 1
2
phosphorilation
(p=0.0156; FC=3.133, n=7) with a maximum stimulatory effect at 1000 nM for
10 minutes. In rats fed with high fat diet for 16 weeks nesfatin-1 cardiac mRNA
levels are higher compared with control (p=0.0111, FC =2.201, n=7) and there
is a positive correlation with body weight (Spearman’s rho (Rho)= 0.715, Sig.
=0.004, n=14) and the fat percentage (Rho= 0.692, Sig. =0.006, n=14). There
is also a positive correlation between plasma nesfatin-1 levels and body weight
(Rho= 0.582, Sig. =0.037, n=13).
Conclusions: In cardiomyocytes nesfatin-1 regulates glucose homeostasis. Car-
diac levels of this adipokine are modified by inflammatory and metabolic status.
Our work provides the first evidences about a potential role of nesfatin-1 in a
paracrine/autocrine system at cardiac level.
NON PHARMACOLOGICAL TREATMENT IN
HYPERTENSION
247 Adherence to the Mediterranean diet and albuminuria
levels in adolescents: Emerging data from the Lyceum
Leontio Albuminuria (3L) Study
K. Dimitriadis, C. Tsioufis, D. Tsiachris, A. Kasiakogias, T. Psaltopoulou,
V. Tzamou, A. Mazaraki, I. Andrikou, C. Pitsavos, C. Stefanadis. First
Cardiology Clinic, University of Athens,Hippokration Hospital, Athens, Greece
Purpose: Mediterranean diet has favorable effects on the cardiovascular system,
while albuminuria is associated with atherosclerosis progression. The aim of the
study was to investigate the relationship of dietary habits with urinary albumin
excretion, expressed as the albumin to creatinine ratio (ACR), in a cohort of ado-
lescents
Methods: A total of 365 adolescents 12-17 years of age [212 males, aged
13.9 years, office blood pressure (BP)=115/67 mmHg] that were included in the
Lyceum Leontio Albuminuria (3L) study were considered for analysis. In all partic-
ipants ACR values were determined in a morning spot urine and for each adoles-
cent a questionnaire was completed on lifestyle and socio-economic characteris-
tics. Moreover, the Mediterranean Diet Quality Index for children and adolescents
(KIDMED) was estimated and accordingly subjects were divided into those with
optimal (≥7), average (4-7) and low (<4) score.
Results: Only 6.8% of the participants had optimal KIDMED score, whereas
51.2% had an average and 42% had a low score. Participants with at least aver-
age KIDMED score (n=187) compared to those with low KIDMED score (n=153)
had higher body mass index (22.2 vs 21.4 kg/m2 , p=0.043) and waist circum-
ference (77.6 vs 75.4 cm, p=0.044), spent more frequently time for sports ac-
tivities outside school (75.2% vs 58%, p=0.001), reported less consumption of
foods outside home (3% vs 14%, p<0.001) and less hours of watching television
(1.75 vs 2.05 hours, p=0.013). Moreover, those with at least average compared
to those with low KIDMED score exhibited higher systolic BP (117 vs 114 mmHg,
p=0.039), whereas had lower heart rate (84 vs 87 bpm, p=0.014) and ACR lev-
els (12.6 vs 20.5 mg/g, p=0.015). In the total population, ACR was associated
with age (r=-0.11, p=0.044), body mass index (r=-0.131, p=0.016), systolic BP
(r=-0.144, p=0.008) and KIDMED score (r=-0.111, p=0.041).
Conclusion: In adolescents there is an inverse relation of KIDMED score with
albuminuria and those who adhere to the Mediterranean diet exhibit lower levels
of ACR. However, the paradoxical associations of both ACR and KIDMED score
with obesity markers and BP levels suggest distinct mechanisms of albuminuria
development in adolescents.
248 Influence of potassium intake on blood pressure of
subjects with different levels of sodium consumption
J.G. Mill1, S.L. Rodrigues1 , M.P. Baldo1 , P. Magalhaes2 ,
D.P. Capingana2 , M.C.B. Molina1 , F. Herkenhoff1 , R.S. Cunha1 .
1Federal University of Espirito Santo, Vitoria, Brazil; 2Faculty of
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Background: Increase of potassium (K) intake has been recommended as a non
pharmacologic strategy to reduce blood pressure (BP) levels and hypertension in-
cidence. However, the benefits of such strategy in subjects with different patterns
of sodium (Na) intake have not been evaluated. In this study we investigated in
a population-based study the influence of the K intake on BP of individuals con-
suming low (<6 g/day) or high (>6 g/day) salt diets.
Methods: A random sample (N=1,661) of the adult (25-64 y) population of Vitória,
Brazil, was recruited to investigate cardiovascular risk factors. BP, anthropometry
and biochemical variables (fasting blood) were obtained according to standard
methods during a programmed visit to the University Hospital. Urine was col-
lected for 12 h (7 pm to 7 am) in the night previous to the hospital visit to as-
sess Na, K and creatinine excretion. Individuals with inadequate urine collection
(n=54), plasma creatinine >1.4 mg/dL (n=52) or under use of any hypertensive
medication, including diuretics (n=270) were excluded from the present analysis.
Variables are shown as mean±standard deviation. Statistical significance was set
atp<0.05.
Results: Data refer to 1,285 subjects (613 men, age = 43±10 y). Hypertension
(bloodpressure ≥140/90 mmHg) was found in 31%, obesity (BMI≥30 kg/2) in
15.5% and diabetes (fasting glicemia >125 mg/dL) in 5.3%. Mean urinary Na and
K excretion was 99±57 mEq and 23±15 mEq/12 h, giving a mean daily consump-
tion of 211 mEq of Na and 78 mEq of K. Higher K intake was associated with
individuals older and with higher BMI and urinary Na excretion. Systolic and dias-
tolic BP mean levels were stable along quartiles of urinary K excretion. However,
significant (P<0.001) decrease was observed for the systolic and diastolic BP
adjusted for age, BMI and 12h Na and creatinine excretion. Interestingly, the as-
sociation between K excretion (as surrogate of K intake) was lost in the subgroup
of subjects (N=182) consuming <6 g salt/day (<1.20 g Na/12-h urine). In subjects
consuming >6 gsalt/day, the adjusted systolic and diastolic BP were, respectively,
7 mmHg and 3 mmHg lower in those in the upper urinary K excretion quartile
(>28 mEq/12h) as compared with those in the lowest one (<14 mEq/12h).
Conclusion: Our data confirm based in data obtained in the general population
that increasing the K intake may partially inhibit the hypertensive effect of high
salt diets. This strategy seems to be more efficient in highr salt consumers.
Financialsupport – CNPq and FINEP
249 Dietary omega-3 acid ethyl esters enhance omega-3
index, attenuate myocardial arrhythmogenic substrate
and protect from malignant arrhythmias in a model of
human essential hypertension
N. Tribulova1 , B. Bacova1 , J. Radosinska2 , T. Benova1 , V. Knezl3 ,
E. Goncalvesova4 , J. Slezak1 . 1Slovak Academy of Sciences, Institute for
Heart Research, Bratislava, Slovak Republic; 2Comenius University, Faculty of
Medicine, Bratislava, Slovak Republic; 3Slovak Academy of Sciences, Institute of
Experimental Pharmacology & Toxicology, Bratislava, Slovak Republic; 4National
Institute of Cardiovascular Diseases (NICVD), Bratislava, Slovak Republic
Background and Purpose: Hypertension-induced myocardial remodeling is
known to be associated with increased propensity to malignant arrhythmias that
can be attributed to impairment of cell-to-cell synchronization due to alterations in
electrical coupling protein, connexin-43 (Cx43). Omega-3 fatty acids (omega-3)
exert cardioprotective and antiarrhythmic effects in both experimental and clinical
setting. We tested our hypothesis that omega-3 intake can protect of hyperten-
sive rats from malignant arrhythmias via protection of intercellular communication
ensured by Cx43 channels.
Design and Methods: Experiments were conducted on male spontaneously hy-
pertensive rats (SHR) at early (3month) and late (12 month) stage of diseases as
well as age-matched normotensive Wistar rats. Untreated rats were compared
with animals supplemented by omega-3 (EPA+DHA ethyl esters, Vesterlanes,
Norway, 30 mg/day) for two month. Blood pressure, body, heart and left ventri-
cle weights were monitored. Plasma and red blood cells (RBC) fatty acids profile
(omega-3 index) was estimated by gas chromatography. Left ventricular tissues
were taken for examination of Cx43 distribution (using immunostaining and elec-
tron microscopy) and expression (using immunoblotting). Expression of protein ki-
nases C (PKC), which phosphorylates Cx43 was examined as well. Langendorff-
isolated heart preparation was used to test inducible VF.
Key results: Comparing to healthy rats the omega-3 index was lower in old SHR
(0.7% vs 2.5%) and increased due to omega-3 intake in both groups to 2.3% and
4.8%. Young SHR rat hearts exhibited LVH associated with enhanced distribu-
tion of Cx43 on lateral surfaces of the cardiomyocytes, while old SHR exhibited
both lateralization and severely disordered distribution of Cx43 at the area of fi-
brosis. Total Cx43 expression was increased in young and decreased in old SHR
hearts but phosphorylated (functional) forms of Cx43 were suppressed in both
SHR groups. In contrast, omega-3 intake diminished arrhythmogenic substrate,
i.e. abnormal Cx43 distribution and attenuated significantly abnormal Cx43 ex-
pression and phosphorylation. The latter was linked with enhanced PKCe ex-
pression. Consequently, omega-3-treated SHR were less prone to inducible VF
comparing to untreated rats.
Conclusions: Results indicate that hypertensive rats benefit from omega-3 fatty
acids supplementation due to an increase of omega-3 index, alleviation of Cx43-
related arrhythmogenic substrate and suppression of malignant arrhythmias.
This work was supported by VEGA 2/0046/12 grant.
250 AT1 receptor blockade attenuates insulin resistance and
myocardial remodeling in rats with diet-induced obesity
S.A. Oliveira Jr1 , M.P. Okoshi1 , P.F. Martinez1 , D.M. Guizoni1 ,
B.P. Torres2 , M. Dal Pai-Silva2, K. Okoshi1 , A.C. Cicogna1 ,
C.R. Padovani2 , A.P. Lima-Leopoldo3 . 1Sao Paulo State University,
Botucatu Medical School, Department of Internal Medicine, Botucatu, Brazil;
2Univ. Estadual Paulista (UNESP), Botucatu Biosciences Institute, Botucatu,
Brazil; 3Federal University of Espirito Santo, Vitoria, Brazil
Interactions between angiotensin-II type 1 (AT1) receptor and insulin has clas-
sically resulted in insulin resistance and cardiac remodeling in obesity. This
study evaluated the influence of AT1 receptor blocker losartan on insulin recep-
tor/phosphatidylinositol 3-kinase (PI3-kinase) pathway and myocardial remodel-
ing in rats with diet-induced obesity.
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